BridgeMD
New treatment option for Sputum
Official title Electromagnetic High-Frequency Chest Wall Oscillation on Pulmonary Mucus Clearance in Patients With Impaired Self-Expectoration
ClinicalTrials.gov ID: NCT07347366
What this study is testing
- What it's testing
- This exploratory study aims to evaluate the efficacy and safety of an electromagnetic high-frequency, low-strain chest wall oscillation device for enhancing pulm
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Hospitalized patients who require sputum clearance.
- Patients who present with fever or respiratory symptoms (cough, sputum) and, after confirmation of findings on imaging studies, are judged by the...
- Adult patients (≥ 18 years) who have signed the informed consent form, or patients for whom consent has been obtained from a legally authorized...
You likely can't join if
- Patients with severe pneumonia requiring intensive care unit (ICU) treatment.
- Patients with major pulmonary diseases other than pneumonia, such as active tuberculosis or lung cancer.
- Patients with severe respiratory failure (PaO₂/FiO₂ ≤ 200 mmHg).
- Patients with hemodynamically unstable cardiovascular disease (myocardial infarction within the past 3 months, or heart failure of NYHA class 3 or...
- Patients hospitalized for head and neck trauma whose surgical site has not yet healed.
- Patients with serious cardiac arrhythmias or hemodynamic instability.
See the full eligibility criteria
- Hospitalized patients who require sputum clearance.
- Patients who present with fever or respiratory symptoms (cough, sputum) and, after confirmation of findings on imaging studies, are judged by the clinician to require sputum clearance.
- Adult patients (≥ 18 years) who have signed the informed consent form, or patients for whom consent has been obtained from a legally authorized representative
- Patients with severe pneumonia requiring intensive care unit (ICU) treatment.
- Patients with major pulmonary diseases other than pneumonia, such as active tuberculosis or lung cancer.
- Patients with severe respiratory failure (PaO₂/FiO₂ ≤ 200 mmHg).
- Patients with hemodynamically unstable cardiovascular disease (myocardial infarction within the past 3 months, or heart failure of NYHA class 3 or higher).
- Patients hospitalized for head and neck trauma whose surgical site has not yet healed.
- Patients with serious cardiac arrhythmias or hemodynamic instability.
- Patients who have had pneumothorax or massive hemoptysis within the past 6 months, or who currently have hemoptysis.
- Patients who have undergone spinal surgery within the past 6 months or who have acute spinal injury.
- Patients with osteoporosis.
- Patients with bronchopleural fistula.
- Pregnant or breastfeeding women.
- Patients diagnosed with cervical disc disease.
- Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months (however, patients enrolled in chronic lung disease...
- Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study
The study team makes the final eligibility decision.
Where it's taking place
- Yangsan, Gyeongsangnam-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yangsan, Gyeongsangnam-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.